4-122897356-A-G

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_001361665.2(FGF2):​c.*4960A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000172 in 407,750 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

FGF2
NM_001361665.2 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.130

Publications

26 publications found
Variant links:
Genes affected
FGF2 (HGNC:3676): (fibroblast growth factor 2) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. [provided by RefSeq, Jul 2008]
NUDT6 (HGNC:8053): (nudix hydrolase 6) This gene overlaps and lies on the opposite strand from FGF2 gene, and is thought to be the FGF2 antisense gene. The two genes are independently transcribed, and their expression shows an inverse relationship, suggesting that this antisense transcript may regulate FGF2 expression. This gene has also been shown to have hormone-regulatory and antiproliferative actions in the pituitary that are independent of FGF2 expression. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FGF2NM_001361665.2 linkc.*4960A>G 3_prime_UTR_variant Exon 3 of 3 ENST00000644866.2 NP_001348594.1
NUDT6NM_007083.5 linkc.553+268T>C intron_variant Intron 4 of 4 ENST00000304430.10 NP_009014.2
FGF2NM_002006.6 linkc.*4960A>G 3_prime_UTR_variant Exon 3 of 3 NP_001997.5
NUDT6NM_198041.3 linkc.46+268T>C intron_variant Intron 4 of 4 NP_932158.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FGF2ENST00000644866.2 linkc.*4960A>G 3_prime_UTR_variant Exon 3 of 3 NM_001361665.2 ENSP00000494222.1
NUDT6ENST00000304430.10 linkc.553+268T>C intron_variant Intron 4 of 4 1 NM_007083.5 ENSP00000306070.5

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
151872
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000442
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000117
AC:
3
AN:
255878
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
134932
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
7094
American (AMR)
AF:
0.00
AC:
0
AN:
8598
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
8232
East Asian (EAS)
AF:
0.00
AC:
0
AN:
16012
South Asian (SAS)
AF:
0.00
AC:
0
AN:
23510
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
15898
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1186
European-Non Finnish (NFE)
AF:
0.0000188
AC:
3
AN:
159944
Other (OTH)
AF:
0.00
AC:
0
AN:
15404
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
151872
Hom.:
0
Cov.:
32
AF XY:
0.0000270
AC XY:
2
AN XY:
74158
show subpopulations
African (AFR)
AF:
0.0000242
AC:
1
AN:
41342
American (AMR)
AF:
0.00
AC:
0
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10554
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000442
AC:
3
AN:
67916
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
2677

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
5.5
DANN
Benign
0.80
PhyloP100
0.13

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1476217; hg19: chr4-123818511; API